E- Case Report
Clinical Response to Ingenol Mebutate in Patients With Actinic Keratoses
Respuesta a ingenol mebutato en los pacientes con queratosis actínicas en la práctica clínica
A. Batalla
, Á. Flórez, C. Feal, G. Peón, M.T. Abalde, L. Salgado-Boquete, C. de la Torre
Autor para correspondencia
Servicio de Dermatología, Centro de Especialidades de Mollabao, Xestión Integrada Pontevedra-Salnés, Pontevedra, Spain
Leído
6788
Vecesse ha leído el artículo
2264
Total PDF
4524
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 22 | 5 | 27 |
| 2025 5 | 146 | 33 | 179 |
| 2025 4 | 118 | 54 | 172 |
| 2025 3 | 99 | 22 | 121 |
| 2025 2 | 130 | 28 | 158 |
| 2025 1 | 80 | 25 | 105 |
| 2024 12 | 66 | 23 | 89 |
| 2024 11 | 81 | 59 | 140 |
| 2024 10 | 71 | 47 | 118 |
| 2024 9 | 73 | 19 | 92 |
| 2024 8 | 98 | 52 | 150 |
| 2024 7 | 88 | 34 | 122 |
| 2024 6 | 97 | 39 | 136 |
| 2024 5 | 70 | 24 | 94 |
| 2024 4 | 88 | 30 | 118 |
| 2024 3 | 75 | 30 | 105 |
| 2024 2 | 56 | 27 | 83 |
| 2024 1 | 48 | 31 | 79 |
| 2023 12 | 78 | 19 | 97 |
| 2023 11 | 88 | 26 | 114 |
| 2023 10 | 63 | 23 | 86 |
| 2023 9 | 75 | 34 | 109 |
| 2023 8 | 44 | 10 | 54 |
| 2023 7 | 83 | 43 | 126 |
| 2023 6 | 67 | 35 | 102 |
| 2023 5 | 69 | 33 | 102 |
| 2023 4 | 64 | 23 | 87 |
| 2023 3 | 73 | 30 | 103 |
| 2023 2 | 62 | 25 | 87 |
| 2022 1 | 54 | 24 | 78 |
| 2022 12 | 85 | 37 | 122 |
| 2022 11 | 31 | 28 | 59 |
| 2022 10 | 44 | 27 | 71 |
| 2022 9 | 40 | 41 | 81 |
| 2022 8 | 32 | 45 | 77 |
| 2022 7 | 27 | 32 | 59 |
| 2022 6 | 29 | 28 | 57 |
| 2022 5 | 68 | 27 | 95 |
| 2022 4 | 73 | 44 | 117 |
| 2022 3 | 59 | 53 | 112 |
| 2022 2 | 48 | 31 | 79 |
| 2021 1 | 86 | 38 | 124 |
| 2021 12 | 42 | 42 | 84 |
| 2021 11 | 80 | 39 | 119 |
| 2021 10 | 100 | 45 | 145 |
| 2021 9 | 52 | 29 | 81 |
| 2021 8 | 36 | 31 | 67 |
| 2021 7 | 39 | 39 | 78 |
| 2021 6 | 27 | 18 | 45 |
| 2021 5 | 35 | 27 | 62 |
| 2021 4 | 67 | 41 | 108 |
| 2021 3 | 54 | 33 | 87 |
| 2021 2 | 68 | 30 | 98 |
| 2020 1 | 44 | 20 | 64 |
| 2020 12 | 41 | 14 | 55 |
| 2020 11 | 52 | 23 | 75 |
| 2020 10 | 38 | 9 | 47 |
| 2020 9 | 54 | 23 | 77 |
| 2020 8 | 30 | 31 | 61 |
| 2020 7 | 29 | 16 | 45 |
| 2020 6 | 65 | 39 | 104 |
| 2020 5 | 41 | 20 | 61 |
| 2020 4 | 43 | 16 | 59 |
| 2020 3 | 65 | 19 | 84 |
| 2020 2 | 5 | 3 | 8 |
| 2020 1 | 6 | 7 | 13 |
| 2019 12 | 8 | 3 | 11 |
| 2019 11 | 4 | 2 | 6 |
| 2019 10 | 0 | 2 | 2 |
| 2019 9 | 4 | 4 | 8 |
| 2019 8 | 4 | 0 | 4 |
| 2019 7 | 4 | 1 | 5 |
| 2019 6 | 4 | 0 | 4 |
| 2019 5 | 6 | 18 | 24 |
| 2019 4 | 2 | 0 | 2 |
| 2019 3 | 4 | 3 | 7 |
| 2019 2 | 2 | 0 | 2 |
| 2019 1 | 1 | 0 | 1 |
| 2018 12 | 11 | 0 | 11 |
| 2018 10 | 5 | 0 | 5 |
| 2018 9 | 8 | 0 | 8 |
| 2018 6 | 0 | 1 | 1 |
| 2018 3 | 1 | 0 | 1 |
| 2018 2 | 23 | 4 | 27 |
| 2018 1 | 30 | 7 | 37 |
| 2017 12 | 33 | 9 | 42 |
| 2017 11 | 31 | 6 | 37 |
| 2017 10 | 21 | 8 | 29 |
| 2017 9 | 20 | 6 | 26 |
| 2017 8 | 19 | 10 | 29 |
| 2017 7 | 16 | 8 | 24 |
| 2017 6 | 26 | 12 | 38 |
| 2017 5 | 19 | 8 | 27 |
| 2017 4 | 37 | 13 | 50 |
| 2017 3 | 17 | 45 | 62 |
| 2017 2 | 18 | 10 | 28 |
| 2016 1 | 22 | 9 | 31 |
| 2016 12 | 17 | 13 | 30 |
| 2016 11 | 25 | 34 | 59 |
| 2016 10 | 18 | 28 | 46 |
| 2016 9 | 0 | 5 | 5 |
| 2016 8 | 0 | 2 | 2 |
| 2016 7 | 2 | 4 | 6 |
| 2016 6 | 1 | 4 | 5 |
| 2016 5 | 0 | 2 | 2 |
| 2016 4 | 0 | 9 | 9 |
| 2016 3 | 0 | 7 | 7 |
| 2016 2 | 0 | 12 | 12 |
| 2015 1 | 0 | 3 | 3 |
Mostrar todo
